Ling Hai
Impact in
-
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Glioma Diagnosis and Treatment
Papers in
-
- Angiogenesis and VEGF in Cancer 2
- RNA modifications and cancer 2
- Glycosylation and Glycoproteins Research 1
-
- Pleural and Pulmonary Diseases 6
- Co-authors
- Zhide Hu (8 shared papers)Yonghong Shi (3 shared papers)Hua Du (3 shared papers)Jing Zhao (2 shared papers)Matthias Schlesner (4 shared papers)Tobias Keßler (4 shared papers)Wolfgang Wick (5 shared papers)Jing Wu (1 shared paper)
- Journals
- Neuro-Oncology (2 papers)Therapeutic Advances in Respiratory Disease (1 paper)Neuro-Oncology Advances (1 paper)Cancer Biology & Therapy (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Ling Hai
21 papers receiving 240 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 52
- Genetics 34
- Developmental Neuroscience 8
- Oncology 47
- Obstetrics and Gynecology 11
Countries citing papers authored by Ling Hai
This map shows the geographic impact of Ling Hai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Hai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Hai more than expected).
Fields of papers citing papers by Ling Hai
This network shows the impact of papers produced by Ling Hai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Hai. The network helps show where Ling Hai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Hai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 31 | |
| 2 | 2021 | 28 | |
| 3 | 2017 | 28 | |
| 4 | 2020 | 23 | |
| 5 | Down-regulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells. | 2014 | 20 |
| 6 | Histopathologic characteristics and immunotypes of perivascular epithelioid cell tumors (PEComa). | 2019 | 18 |
| 7 | 2022 | 15 | |
| 8 | 2020 | 15 | |
| 9 | 2020 | 15 | |
| 10 | Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression. | 2014 | 12 |
| 11 | 2023 | 10 | |
| 12 | 2022 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2024 | 4 | |
| 15 | 2025 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2019 | 1 | |
| 20 | 2023 | 1 |
About Ling Hai
Ling Hai is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Oncology, having authored 24 papers that have together received 242 indexed citations. Recurring topics across this work include Pleural and Pulmonary Diseases (6 papers), Glioma Diagnosis and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Angiogenesis and VEGF in Cancer (2 papers), RNA modifications and cancer (2 papers), Glycosylation and Glycoproteins Research (1 paper), Cancer Genomics and Diagnostics (1 paper) and E-commerce and Technology Innovations (1 paper). The work is most often cited by research in Cancer Research (52 citations), Genetics (34 citations), Developmental Neuroscience (8 citations), Oncology (47 citations) and Obstetrics and Gynecology (11 citations). Ling Hai has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Zhide Hu, Yonghong Shi, Hua Du, Jing Zhao, Matthias Schlesner, Tobias Keßler, Wolfgang Wick, Jing Wu, Frank Winkler and Fang Wang. Their work appears in journals such as Neuro-Oncology, Therapeutic Advances in Respiratory Disease, Neuro-Oncology Advances, Cancer Biology & Therapy and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.